$41.59
$0.00 (0.00%)
End-of-day quote: 04/27/2024
NasdaqGS:IONS
Ionis Pharmaceuticals Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| PFE | Pfizer | NYSE | Outperform | $25.40 | $32.87 | 0.00% | 6 | $147.23B |
| AMGN | Amgen | NasdaqGS | Outperform | $269.98 | $303.65 | 0.00% | 8 | $144.81B |
| SAN | Sanofi | ENXTPA | Outperform | 91.23€ | 102.80€ | 0.00% | 9 | 109.51€B |
| REGN | Regeneron Pharmaceuticals | NasdaqGS | Outperform | $883.20 | $961.26 | 0.00% | 8 | $96.37B |
| CSL | CSL | ASX | Outperform | $273.30 | $205.51 | 0.00% | 5 | $130.23B |
| 4568 | Daiichi Sankyo Company | TSE | Buy | ¥5.01k | ¥5.24k | 0.00% | 0 | ¥9.61T |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.09k | ¥4.74k | 0.00% | 0 | ¥6.38T |
| MRNA | Moderna | NasdaqGS | Outperform | $107.97 | $135.42 | 0.00% | 1 | $38.83B |
| BIIB | Biogen | NasdaqGS | Outperform | $208.90 | $299.62 | 0.00% | 13 | $29.36B |
| ALNY | Alnylam Pharmaceuticals Inc | NASDAQ | Outperform | $143.31 | $245.24 | 0.00% | 7 | $18.26B |
| BMRN | BioMarin Pharmaceutical | NasdaqGS | Outperform | $80.91 | $111.56 | 0.00% | 5 | $15.36B |
| INCY | Incyte | NasdaqGS | Outperform | $51.68 | $77.05 | 0.00% | 8 | $11.75B |
| SRPT | Sarepta Therapeutics | NasdaqGS | Outperform | $128.77 | $158.66 | 0.00% | 6 | $10.85B |
| JAZZ | Jazz Pharmaceuticals | NasdaqGS | Outperform | $109.46 | $188.32 | 0.00% | 4 | $6.85B |
| EXEL | Exelixis | NasdaqGS | Outperform | $23.70 | $26.44 | 0.00% | 5 | $6.21B |
| NTLA | Intellia Therapeutics | NasdaqGM | Outperform | $20.76 | $75.84 | 0.00% | 21 | $2.51B |
| DYN | Dyne Therapeutics | NasdaqGS | Buy | $24.73 | $28.13 | 0.00% | 0 | $2.06B |
| 4516 | Nippon Shinyaku | TSE | Outperform | ¥4.34k | ¥8.34k | 0.00% | 0 | ¥283.22B |
| DCPH | Deciphera Pharmaceuticals | NasdaqGS | Outperform | $14.65 | $23.40 | 0.00% | 4 | $1.29B |
| BCRX | BioCryst Pharmaceuticals | NasdaqGS | Outperform | $4.16 | $14.09 | 0.00% | 2 | $1.19B |
| WVE | Wave Life Sciences | NasdaqGM | Outperform | $4.66 | $9.21 | 0.00% | 3 | $768.25M |
| PHARM | Pharming Group N.V. | ENXTAM | Buy | 0.90€ | 1.85€ | 0.00% | 2 | 593.30€M |
| STOK | Stoke Therapeutics | NasdaqGS | Buy | $12.41 | $19.33 | 0.00% | 3 | $624.90M |
| KALV | KalVista Pharmaceuticals | NasdaqGM | Buy | $10.78 | $20.80 | 0.00% | 0 | $597.02M |
| ABUS | Arbutus Biopharma | NasdaqGS | Outperform | $2.73 | $6.34 | 0.00% | 0 | $474.02M |
| FULC | Fulcrum Therapeutics | NasdaqGM | Outperform | $7.14 | $10.21 | 0.00% | 7 | $425.13M |
| PYC | PYC Therapeutics | ASX | Buy | $0.09 | $0.30 | 0.00% | 1 | $294.90M |
